Frederic Maas Genannt Bermpohl

Frederic Maas Genannt Bermpohl

Auto-generated profile, based on publicly available information

Frederic Maas Genannt Bermpohl

University of Wuppertal, Department of Clinical Psychology and Psychotherapy, School of Human and Social Sciences, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2024 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
CRCaroline Rometsch
Caroline Rometsch
GMGiovanni Mansueto
Giovanni Mansueto
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
AMAlexandra Martin
Alexandra Martin
FCFiammetta Cosci
Fiammetta Cosci
Functional Disorders (FD) refer to persistent somatic symptoms caused by changes in the functioning of bodily processes. Previous findings suggest that FD are highly prevalent, but overall prevalence rates for FD in European countries are scarce. Therefore, the aim of the present work was to estimate the point prevalence of FD in adult general populations. PubMed and Web of Science were searched from inception to June 2022. A generalized linear mixed-effects model for statistical aggregation was used for statistical analyses. A standardized quality assessment was performed, and PRISMA guidelines were followed. A total of 136 studies were included and systematically synthesized resulting in 8 FD diagnoses. The large majority of studies was conducted in the Northern Europe, Spain, and Italy. The overall point prevalence for FD was 8.78% (95% CI from 7.61 to 10.10%) across Europe, with the highest overall point prevalence in Norway (17.68%, 95% CI from 9.56 to 30.38%) and the lowest in Denmark (3.68%, 95% CI from 2.08 to 6.43%). Overall point prevalence rates for specific FD diagnoses resulted in 20.27% (95% CI from 16.51 to 24.63%) for chronic pain, 9.08% (95% CI from 7.31 to 11.22%) for irritable bowel syndrome, and 8.45% (95% CI from 5.40 to 12.97%) for chronic widespread pain. FD are highly prevalent across Europe, which is in line with data worldwide. Rates implicate the need to set priorities to ensure adequate diagnosis and care paths to FD patients by care givers and policy makers.

20 April 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
LHLea Hülsmann
Lea Hülsmann
AMAlexandra Martin
Alexandra Martin
Objective: Bodily distress, i.e., somatoform disorders and associated functional somatic syndromes, is highly prevalent, often persistent and highly disabling. It has been proposed that “third wave” therapies may be beneficial variants of cognitive behavioral treatments. However, evidence on their efficacy is scarce. This meta-analysis examines the efficacy of “third wave” psychotherapies (mindfulness-based cognitive therapy [MBCT], mindfulness-based stress reduction [MBSR], and acceptance and commitment therapy [ACT]) in adults with bodily distress.Method: We included randomized controlled trials (RCTs) treating adults with bodily distress using MBCT, MBSR, and ACT compared to inactive and non-specific control groups. A random effects model was used. The primary outcome was somatic symptom severity. Secondary outcomes were degrees of depression and of anxiety, health anxiety, perceived health status, mindfulness, psychological inflexibility, and pain acceptance.Results: Sixteen RCTs with 1,288 participants were included in the analysis (k = 4 MBCT, k = 7 MBSR, k = 5 ACT; k = 7 fibromyalgia, k = 5 irritable bowel syndrome, k = 1 chronic fatigue syndrome, k = 2 bodily distress, k = 1 medically unexplained symptoms). However, not all studies provided data for each of the relevant outcomes. The analyses revealed that “third wave“ therapies were more effective than control conditions in reducing somatic symptom severity (k = 15, n = 1,100, g = −0.51, 95%CI −0.69; −0.32). Heterogeneity was moderate (I2 = 52.8%, 95%CI 15.1 to 73.8). Effects for secondary outcomes were small to moderate with varying degrees of heterogeneity. We did not find differences between the different therapy approaches (mindfulness- vs. acceptance-based therapies); neither therapy dosis (i.e., total duration of therapy sessions) nor number of sessions were significant moderators of efficacy.Conclusions: The therapies addressing mindfulness and acceptance proved to be more effective than control conditions. Hence, they are promising treatment approaches for bodily distress. However, there is still need for research on which patient groups may benefit from these psychological approaches.Systematic review registration: https://osf.io/g7hby, identifier: 10.17605/OSF.IO/4RZGC.

16 January 2024 in International Journal of Behavioral Medicine
Verified
Journal Article
Open access
PDF file
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
AKAnn-Cathrin Kucharczyk-Bodenburg
Ann-Cathrin Kucharczyk-Bodenburg
AMAlexandra Martin
Alexandra Martin
Background: The systematic aggregation of research on cognitive behavioral therapy (CBT) in chronic fatigue syndrome (CFS) needs an update. Although meta-analyses evaluating interventions typically focus on symptom reduction, they should also consider indicators of treatment acceptability, e.g., drop-out rates. Methods: Randomized controlled trials (RCTs) investigating CBT in adults with CFS compared to inactive and non-specific control groups were included. First, efficacy was examined, considering fatigue, depression, anxiety, and perceived health. Secondly, drop-out rates through different trial stages were analyzed: Non-completion of all mandatory sessions, drop-out (primary study definition), treatment refusal (non-starters), and average of sessions completed. Result: We included 15 RCTs with 2015 participants. CBT was more effective than controls in fatigue (g = -0.52, 95%CI -0.69 to -0.35), perceived health, depression, and anxiety at post-treatment. At long-term follow-up the effects were maintained for fatigue and anxiety. Rates of non-completion (22%, 95%CI 3–71), drop-out (15%, 95%CI 9–25), and treatment refusal (7%, 95%CI 3–15) were relatively low, with a high average proportion of sessions completed. Total time of therapy moderated the effect on fatigue, while the number of sessions moderated the effect on perceived health. Fatigue severity influenced adherence. Conclusion: The results indicate that CBT for CFS is effective in reducing fatigue, fatigue related impairment, and severity of depression and anxiety. Conclusions on efficacy at follow-ups are still limited. However, adherence is high in CBT. The results may help to inform clinical practice. Future research should focus on examining the maintenance of effects, while also emphasizing the importance of treatment acceptance.

24 February 2025 in Psychotherapy and Psychosomatics
Verified
Journal Article
Open access
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
AMAlexandra Martin
Alexandra Martin
Introduction: Many physical complaints cause long-term bodily distress. Meta-analyses show that cognitive behavioral therapy (CBT) and acceptance- and mindfulness-based treatments (AMBT) reduce somatic symptom severity, but evidence on differential efficacy is limited. This study evaluates the efficacy of CBT and AMBT for bodily distress (e.g., somatoform disorders, functional somatic syndromes, and related disorders). Methods: A network meta-analysis of randomized controlled trials on adults with bodily distress compared CBT and AMBT either directly or with nonspecific control groups. Cohen’s d based on between-group effect sizes was aggregated using a random effects model. Primary outcome was somatic symptom severity; secondary outcomes included depression, anxiety, and perceived health status. Results: Based on 74 studies (N = 8,277), CBT (d = −0.50, 95% CI, −0.70 to −0.29; between-group effect sizes vs. wait-list [WL]) and AMBT (d = −0.55, 95% CI, −1.06 to −0.23; between-group effect sizes vs. WL) were equally effective in reducing somatic symptoms at posttreatment. AMBT were more effective than CBT in reducing depression (d = −0.31, 95% CI, −0.58 to −0.04; between-group effect sizes) and anxiety (d = −0.42, 95% CI, −0.73 to −0.11; between-group effect sizes) posttreatment. At long-term follow-up, effects were partly maintained; AMBT remained more effective than CBT for anxiety, with no differential effects for other outcomes. Conclusions: Both treatments showed benefits compared to various controls. Evidence suggests potential differential treatment effects, indicating some patient groups may benefit more from AMBT. Clinicians should view CBT as foundational but remain open to variations, especially for comorbid pathology.

4 February 2026 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
CSChristina Schut
Christina Schut
JMJohanna Munz
Johanna Munz
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
ALAntoinette I.M. Van Laarhoven
Antoinette I.M. Van Laarhoven
JSJennifer Schmidt
Jennifer Schmidt
JKJörg Kupfer
Jörg Kupfer
Psychological interventions reduce itch in patients with skin diseases. However, previous systematic reviews and meta-analyses did not include patients with non-skin-related chronic itch and did not consider excoriations as outcome. This study therefore summarized randomized controlled trials investigating effects of psychological interventions on itch, scratching, and excoriations in patients with chronic itch due to all causes. A systematic literature search was conducted. A random effects model was used to aggregate between-group effect sizes. It was found that 17 of the 20 trials included patients with atopic dermatitis. Small to large post-treatment and follow-up effects were observed on self-rated itch intensity (post-treatment: k = 12, g = –0.37 [–0.60; –0.15]; follow-up: k = 6; g = –0.59 [–0.97; –0.21]), externally rated excoriations (post-treatment: k = 6, g = –0.29 [–0.49; –0.09]; follow-up: k = 6; g = –0.34 [–0.53; –0.15]), and self-rated scratching intensity (post-treatment: k = 2, g = –0.99 [–1.35; –0.63]; follow-up: k = 2; g = –0.85 [–1.22; –0.48]). Small post-treatment effects were observed on self-rated itch frequency (k = 3, g = –0.22 [–0.40; –0.04]). Thus, psychological interventions show promise in reducing not only itch and scratching, but also excoriations, with effects lasting up to 1 year.

16 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LILavinia Ivan
Lavinia Ivan
PFPetra Foerster
Petra Foerster
FBFrederic Maas Genannt Bermpohl
Frederic Maas Genannt Bermpohl
AGAlexander L. Gerlach
Alexander L. Gerlach
APAnna Pohl
Anna Pohl
Objective: The purpose of this meta-analysis is to give an overview of the relationships between positive and negative metacognitions (PMC, NMC) with health anxiety and pathological safety seeking and avoidant behavior (SSB, AB). Method: The preregistered systematic literature screening included following data bases: MEDLINE, PsycINFO, PSYNDEX, PubMed, The Cochrane Library, Web of Science, ProQuest Dissertations & Theses, and The German National Library. The studies were evaluated based on predefined eligibility criteria (i.e., data for PMC/NMC and health anxiety and/ or SSB/AB from adult samples, assessed with validated inventories and presented in English or German language) and risk of bias categories. Correlation coefficients were aggregated with random effect models. Publication biases were estimated with contour enhanced funnel plots and outlier analyses. Results: 23 studies (N = 9229) were included in the meta-analysis. Most studies assessed health anxiety in analogue samples. A significant medium effect was found for PMC and health anxiety (r = .36, p < 0.0001, 95% CI:.29 ≤ r ≤ .43), whereas for NMC the effect was large (r = .52, p < 0.0001, 95% CI:.46 ≤ r ≤ .58). For the relationship with SSB the results revealed a moderate effect for PMC (r = 0.31, p = .004; 95%-CI: 0.19 ≤ r ≤ 0.42) and a small effect for NMC (r = .25, p = .02, 95% CI:.05 ≤ r ≤ .43). No study assessed AB. Discussion: Metacognitions are a significant pathological factor in health anxiety, with particularly strong association with NMC. PMC might be of special interest for health anxiety and SSB compared to other psychopathologies. Heterogeneity, missing clinical samples and studies on AB limit generalizability. Future research should further explore the role of metacognitions in health anxiety and focus on the relation with pathological SSB and AB.